Allschwil, Switzerland

Hans Tscherter


Average Co-Inventor Count = 3.2

ph-index = 5

Forward Citations = 99(Granted Patents)


Location History:

  • Neuallschwil, CH (1977)
  • Allschwil, CH (1979 - 1997)

Company Filing History:


Years Active: 1977-1997

Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Hans Tscherter

Introduction

Hans Tscherter, an accomplished inventor based in Allschwil, Switzerland, has made significant contributions to the field of pharmacology. With a total of eight patents to his name, his work has highlighted the potential of peptolides in medicinal applications.

Latest Patents

His latest patents include a focus on pipecolic acid-containing peptolides and their preparation. The innovation describes compounds with peptidic backbones consisting of at least nine alpha-amino acid residues, which can be derived from specific microorganism strains, such as S 42508/F (NRRL 15761). These compounds are noted for their promising pharmacological properties, including antifungal capabilities, chemotherapeutic drug resistance reversal, and potential immunosuppressant and anti-inflammatory effects. Additionally, Tscherter has explored cyclic peptolides resembling cyclosporins, featuring unique modifications that provide immunosuppressive, anti-inflammatory, and anti-parasitic properties through fermentation processes with fungi from the genus Cylindrotrichum Bonorden or hydroxy-undecapeptide cyclization.

Career Highlights

As a member of Sandoz GmbH, Tscherter's career has been marked by a dedication to researching and developing innovative compounds that offer therapeutic benefits. His work not only advances pharmaceutical science but also enhances treatment options for patients facing various health challenges.

Collaborations

Throughout his career, Tscherter has collaborated with notable colleagues, including Michael Morris Dreyfuss and Hans Kobel. These partnerships reflect a commitment to collective innovation within the industry, facilitating the advancement of research and development in pharmacological applications.

Conclusion

Hans Tscherter's innovative work at Sandoz GmbH and his eight patents showcase the importance of continued research in the realm of medicinal chemistry. His contributions to the development of pipecolic acid-containing peptolides demonstrate the intersection of science and innovation in addressing therapeutic needs in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…